Clay Thorp insider trades: Clearside Biomedical (CLSD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Clay reports to the SEC
Open-market buys and sales
47 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | CLSD | ↑ Buy | 15,000 | $0.92 | $14K | Direct | Feb 24, 2025 (0d) |
| Sep 25, 2023 | CLSD | ↑ Buy | 10,000 | $0.86 | $9K | Direct | Sep 25, 2023 (0d) |
| Dec 21, 2022 | CLSD | ↑ Buy | 14,000 | $1.02 | $14K | Direct | Dec 21, 2022 (0d) |
| May 17, 2022 | VIGL | ↑ Buy | 36,695 | $2.85 | $104K | By Hatteras Venture Partners VI, L.P. | May 17, 2022 (0d) |
| Mar 28, 2022 | VIGL | ↑ Buy | 3,000 | $7.20 | $22K | Direct | Mar 28, 2022 (0d) |
| Jan 11, 2022 | VIGL | ↑ Buy | 265,000 | $14.00 | $3.7M | By Hatteras Venture Partners VI, L.P. | Jan 11, 2022 (0d) |
| Aug 18, 2021 | PHAS | ↑ Buy | 10,000 | $3.00 | $30K | Direct | Aug 18, 2021 (0d) |
| Feb 10, 2021 | CLSD | ↓ Sell | 32,873 | $4.43 | $146K | Indirect | Feb 12, 2021 (2d) |
| Nov 24, 2020 | PHAS | ↑ Buy | 5,000 | $3.60 | $18K | Direct | Nov 24, 2020 (0d) |
| Jul 1, 2019 | PHAS | ↓ Sell | 2,014 | $14.00 | $28K | By Hatteras Venture Partners III, LP | Jul 3, 2019 (2d) |
| Jul 1, 2019 | PHAS | ↓ Sell | 459 | $14.00 | $6K | By Venture Capital Multiplier Fund | Jul 3, 2019 (2d) |
| Jul 1, 2019 | PHAS | ↓ Sell | 255 | $14.00 | $4K | By Hatteras Venture Partners I, LP | Jul 3, 2019 (2d) |
| Jul 1, 2019 | PHAS | ↓ Sell | 180 | $14.00 | $3K | By Hatteras Venture Affiliates III, LP | Jul 3, 2019 (2d) |
| Jun 18, 2019 | PHAS | ↓ Sell | 277 | $14.00 | $4K | By Hatteras Venture Partners III, LP | Jun 20, 2019 (2d) |
| Jun 18, 2019 | PHAS | ↓ Sell | 63 | $14.00 | $882 | By Venture Capital Multiplier Fund | Jun 20, 2019 (2d) |
| Jun 18, 2019 | PHAS | ↓ Sell | 35 | $14.00 | $490 | By Hatteras Venture Partners I, LP | Jun 20, 2019 (2d) |
| Jun 18, 2019 | PHAS | ↓ Sell | 25 | $14.00 | $350 | By Hatteras Venture Affiliates III, LP | Jun 20, 2019 (2d) |
| Dec 6, 2018 | CLSD | ↑ Buy | 8,000 | $1.36 | $11K | Direct | Dec 6, 2018 (0d) |
| Dec 4, 2018 | PHAS | ↑ Buy | 4,000 | $3.13 | $13K | Direct | Dec 6, 2018 (2d) |
| Oct 22, 2018 | PHAS | ↑ Buy | 150,000 | $5.00 | $750K | By Venture Capital Multiplier Fund | Oct 24, 2018 (2d) |
| Oct 22, 2018 | PHAS | ↑ Buy | 137,513 | $5.00 | $688K | By Hatteras Venture Partners III, LP | Oct 24, 2018 (2d) |
| Oct 22, 2018 | PHAS | ↑ Buy | 12,487 | $5.00 | $62K | By Hatteras Venture Affiliates III, LP | Oct 24, 2018 (2d) |
| May 30, 2018 | GTHX | ↓ Sell | 800,000 | $48.00 | $38.4M | Indirect | Jun 1, 2018 (2d) |
| May 23, 2018 | GTHX | ↓ Sell | 37,500 | $51.11 | $1.9M | Indirect | May 23, 2018 (0d) |
| May 18, 2018 | CLSD | ↓ Sell | 161,139 | $13.08 | $2.1M | Indirect | May 21, 2018 (3d) |
| Mar 23, 2018 | CLSD | ↓ Sell | 138,861 | $12.21 | $1.7M | Indirect | Mar 23, 2018 (0d) |
| Dec 7, 2017 | CLSD | ↓ Sell | 35,000 | $6.22 | $218K | Indirect | Dec 7, 2017 (0d) |
| Nov 16, 2017 | CLSD | ↓ Sell | 35,000 | $7.00 | $245K | Indirect | Nov 16, 2017 (0d) |
| Oct 5, 2017 | CLSD | ↓ Sell | 35,000 | $8.57 | $300K | Indirect | Oct 5, 2017 (0d) |
| Sep 15, 2017 | CLSD | ↓ Sell | 24,500 | $7.52 | $184K | Indirect | Sep 15, 2017 (0d) |
| Aug 9, 2017 | CLSD | ↓ Sell | 24,500 | $7.57 | $185K | Indirect | Aug 9, 2017 (0d) |
| May 22, 2017 | GTHX | ↑ Buy | 133,333 | $15.00 | $2.0M | By Hatteras Venture Partners IV SBIC, LP | May 24, 2017 (2d) |
| May 19, 2017 | CLSD | ↓ Sell | 24,000 | $8.36 | $201K | Indirect | May 19, 2017 (0d) |
| May 17, 2017 | CLSD | ↓ Sell | 44,485 | $8.63 | $384K | Indirect | May 17, 2017 (0d) |
| Apr 19, 2017 | CLSD | ↓ Sell | 68,485 | $7.46 | $511K | Indirect | Apr 19, 2017 (0d) |
| Mar 16, 2017 | CLSD | ↓ Sell | 68,485 | $6.56 | $450K | Indirect | Mar 17, 2017 (1d) |
| Feb 22, 2017 | CLSD | ↓ Sell | 27,000 | $7.55 | $204K | Indirect | Feb 22, 2017 (0d) |
| Feb 17, 2017 | CLSD | ↓ Sell | 41,485 | $7.60 | $315K | Indirect | Feb 17, 2017 (0d) |
| Jan 20, 2017 | CLSD | ↓ Sell | 68,485 | $8.53 | $584K | Indirect | Jan 20, 2017 (0d) |
| Jan 19, 2017 | CLSD | ↓ Sell | 29,656 | $8.63 | $256K | Indirect | Jan 19, 2017 (0d) |
| Jan 19, 2017 | CLSD | ↓ Sell | 25,301 | $8.63 | $218K | Indirect | Jan 19, 2017 (0d) |
| Jun 7, 2016 | CLSD | ↑ Buy | 785,714 | $7.00 | $5.5M | Indirect | Jun 7, 2016 (0d) |
| Jun 7, 2016 | CLSD | ↑ Buy | 414,286 | $7.00 | $2.9M | By Hatteras Venture Partners IV SBIC, LP | Jun 7, 2016 (0d) |
| Jun 7, 2016 | CLSD | ↑ Buy | 107,142 | $7.00 | $750K | Indirect | Jun 7, 2016 (0d) |
| Jun 7, 2016 | CLSD | ↓ Sell | 138 | $7.00 | $966 | Indirect | Jun 7, 2016 (0d) |
| Jun 7, 2016 | CLSD | ↓ Sell | 69 | $7.00 | $483 | Indirect | Jun 7, 2016 (0d) |
| Jun 7, 2016 | CLSD | ↓ Sell | 69 | $7.00 | $483 | By Hatteras Venture Partners IV SBIC, LP | Jun 7, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Clay Thorp's insider trades
Clay Thorp is an insider at Clearside Biomedical (CLSD). Since Jun 7, 2016, Clay has reported 17 open-market purchases worth $16.6M and 30 sales worth $48.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), conversions (6 filings), option exercises (5 filings), other transactions (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CLSD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.